Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T20:36:47.469Z Has data issue: false hasContentIssue false
  • English
  • Français

Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users

Published online by Cambridge University Press:  08 November 2007

T. Schilt ,
M. M. L. de Win ,
G. Jager ,
M. W. Koeter ,
N. F. Ramsey ,
B. Schmand  and
W. van den Brink
T. Schilt*
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, The Netherlands Amsterdam Institute for Addiction Research, The Netherlands
M. M. L. de Win
Affiliation:
Department of Radiology, Academic Medical Center, University of Amsterdam, The Netherlands
G. Jager
Affiliation:
Department of Neurosurgery, University Medical Center Utrecht, The Netherlands
M. W. Koeter
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, The Netherlands Amsterdam Institute for Addiction Research, The Netherlands
N. F. Ramsey
Affiliation:
Department of Neurosurgery, University Medical Center Utrecht, The Netherlands
B. Schmand
Affiliation:
Department of Neurology, Academic Medical Center, University of Amsterdam, The Netherlands Department of Psychology, University of Amsterdam, The Netherlands
W. van den Brink
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, The Netherlands Amsterdam Institute for Addiction Research, The Netherlands
*
*Address for correspondence: T. Schilt, M.Sc., Department of Psychiatry, PBO 429, Academic Medical Center – University of Amsterdam, PO Box 75867, 1070 AW Amsterdam, The Netherlands. (Email: t.schilt@amc.uva.nl)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

A large number of studies, reviews and meta-analyses have reported cognitive deficits in ecstasy users. However most ecstasy users are polydrug users, and therefore it cannot be excluded that these deficits are (partly) the result of drugs other than ecstasy. The current study, part of the Netherlands XTC Toxicity (NeXT) study, investigates the specific sustained effects of ecstasy relative to amphetamine, cocaine and cannabis on the brain using neuropsychological examination.

Method

A stratified sample of 67 subjects with such a variation in type and amount of drug use was included that correlations between the consumption of the various drugs were relatively low allowing stepwise linear multiple regression analyses to differentiate between the effects of ecstasy and those of other substances. Subjects were assessed with neuropsychological tests measuring attention, working memory, verbal and visuospatial memory, and visuospatial ability.

Results

Ecstasy use [mean 327 (s.d.=364) tablets in lifetime] had a specific significant dose-related negative effect on verbal delayed recall after adjusting for the use of other drugs.

Conclusions

These findings strongly suggest a specific sustained negative effect of ecstasy use on verbal memory. The clinical relevance is not immediately clear, because test performance generally remained within the normal range. However the magnitude of the effect is substantial (d>0.5) and long-term consequences cannot be excluded.

Keywords

cannabiscognitionecstasyMDMAmemoryneuropsychologyneurotoxicitypolydrug use
Type
Original Articles
Information
Psychological Medicine , Volume 38 , Issue 9 , September 2008 , pp. 1309 - 1317
Copyright
Copyright © 2007 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Benton, AL, Varney, NR, Hamsher, KD (1978). Visuospatial judgment. A clinical test. Archives of Neurology 35, 364–367.CrossRefGoogle ScholarPubMed
Bolla, KI, McCann, UD, Ricaurte, GA (1998). Memory impairment in abstinent MDMA (‘ecstasy’) users. Neurology 51, 1532–1537.CrossRefGoogle ScholarPubMed
Bolla, KI, Rothman, R, Cadet, JL (1999). Dose-related neurobehavioral effects of chronic cocaine use. Journal of Neuropsychiatry and Clinical Neurosciences 11, 361–369.CrossRefGoogle ScholarPubMed
Burgess, PW, Shallice, T (1996). Confabulation and the control of recollection. Memory 4, 359–411.CrossRefGoogle ScholarPubMed
Compton, WM, Thomas, YF, Conway, KP, Colliver, JD (2005). Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry 162, 1494–1502.CrossRefGoogle ScholarPubMed
Croft, RJ, Mackay, AJ, Mills, AT, Gruzelier, JG (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology (Berlin) 153, 373–379.CrossRefGoogle ScholarPubMed
Dafters, RI, Hoshi, R, Talbot, AC (2004). Contribution of cannabis and MDMA (‘ecstasy’) to cognitive changes in long-term polydrug users. Psychopharmacology (Berlin) 173, 405–410.CrossRefGoogle ScholarPubMed
de Win, MM, Jager, G, Vervaeke, HK, Schilt, T, Reneman, L, Booij, J, Verhulst, FC, den Heeten, GJ, Ramsey, NF, Korf, DJ, van den Brink, W (2005). The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research 14, 167–185.CrossRefGoogle ScholarPubMed
Drugs Informatie en Monitoring System (2004). Jaarbericht 2004. DIMS/Trimbos-instituut: Utrecht, The Netherlands.Google Scholar
Fox, HC, Toplis, AS, Turner, JJ, Parrott, AC (2001). Auditory verbal learning in drug-free ecstasy polydrug users. Human Psychopharmacology 16, 613–618.CrossRefGoogle ScholarPubMed
Gouzoulis-Mayfrank, E, Daumann, J (2006 a). Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101, 348–361.CrossRefGoogle ScholarPubMed
Gouzoulis-Mayfrank, E, Daumann, J (2006 b). The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Journal of Psychopharmacology 20, 188–193.CrossRefGoogle ScholarPubMed
Gouzoulis-Mayfrank, E, Thimm, B, Rezk, M, Hensen, G, Daumann, J (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-Psychopharmacological and Biological Psychiatry 27, 819–827.CrossRefGoogle ScholarPubMed
Graham, FK, Kendall, BS (1960). Memory-for-design: revised general manual. Perceptual and Motor Skills 11, 147–188.CrossRefGoogle Scholar
Green, AR, Mechan, AO, Elliott, JM, O'Shea, E, Colado, MI (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Pharmacological Reviews 55, 463–508.CrossRefGoogle ScholarPubMed
Gronwall, DM (1977). Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and Motor Skills 44, 367–373.CrossRefGoogle ScholarPubMed
Hampson, AJ, Grimaldi, M, Lolic, M, Wink, D, Rosenthal, R, Axelrod, J (2000). Neuroprotective antioxidants from marijuana. Annals of the New York Academy of Science 899, 274–282.CrossRefGoogle ScholarPubMed
Huisman, S (2005). Criminaliteitsbeeldanalyse Synthetische Drugs 2002–2004. Korps Landelijke Politiediensten/Dienst Nationale Recherche (KLPD/NR): Driebergen.Google Scholar
Lindeboom, J, Matto, D (1994). Digit series and Knox cubes as concentration tests for elderly subjects [in Dutch]. Tijdschrift voor Gerontologie en Geriatrie 25, 63–68.Google ScholarPubMed
McKetin, R, Mattick, RP (1998). Attention and memory in illicit amphetamine users: comparison with non-drug-using controls. Drug and Alcohol Dependence 50, 181–184.CrossRefGoogle ScholarPubMed
Medina, KL, Shear, PK, Corcoran, K (2005). Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective. Journal of the International Neuropsychological Society 11, 753–765.CrossRefGoogle ScholarPubMed
Meneses, A (1999). 5-HT system and cognition. Neuroscience and Biobehavioral Reviews 23, 1111–1125.CrossRefGoogle ScholarPubMed
Montgomery, C, Fisk, JE, Newcombe, R (2005 a). The nature of ecstasy-group related deficits in associative learning. Psychopharmacology (Berlin) 180, 141–149.CrossRefGoogle ScholarPubMed
Montgomery, C, Fisk, JE, Newcombe, R, Murphy, PN (2005 b). The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology (Berlin) 182, 262–276.CrossRefGoogle ScholarPubMed
Moscovitch, M, Melo, B (1997). Strategic retrieval and the frontal lobes: evidence from confabulation and amnesia. Neuropsychologia 35, 1017–1034.CrossRefGoogle ScholarPubMed
Nabben, T, Quaak, L, Korf, DJ (2005). NL. Trendwatch. Gebruikersmarkt uitgaansdrugs in Nederland 2004–2005. Rozenberg Publishers: Amsterdam.Google Scholar
Nelson, HE, O'Connell, A (1978). Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14, 234–244.CrossRefGoogle ScholarPubMed
Parrott, AC, Buchanan, T, Scholey, AB, Heffernan, T, Ling, J, Rodgers, J (2002). Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Human Psychopharmacology 17, 309–312.CrossRefGoogle ScholarPubMed
Parrott, AC, Gouzoulis-Meyfrank, E, Rodgers, J, Solowij, N (2004). Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects. Journal of Psychopharmacology 18, 572–575.CrossRefGoogle ScholarPubMed
Pedersen, W, Skrondal, A (1999). Ecstasy and new patterns of drug use: a normal population study. Addiction 94, 1695–1706.CrossRefGoogle ScholarPubMed
Reneman, L, de Win, MM, van den Brink, W, Booij, J, den Heeten, GJ (2006). Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology 20, 164–175.CrossRefGoogle ScholarPubMed
Rey, A (1964). L'Examen Clinique en Psychologie. Presses Universitaires de France: Paris.Google Scholar
Ricaurte, GA, Yuan, J, McCann, UD (2000). (±)3,4-Methylenedioxymethamphetamine (‘ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42, 5–10.CrossRefGoogle ScholarPubMed
Rodgers, J, Buchanan, T, Scholey, AB, Heffernan, TM, Ling, J, Parrott, AC (2003). Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study. Journal of Psychopharmacology 17, 389–396.CrossRefGoogle ScholarPubMed
Schilt, T, de Win, MM, Koeter, M, Jager, G, Korf, DJ, van den Brink, W, Schmand, B (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry 64, 728–736.CrossRefGoogle ScholarPubMed
Schmand, B, Bakker, D, Saan, R, Louman, J (1991). The Dutch Reading Test for Adults: a measure of premorbid intelligence level [in Dutch]. Tijdschrift voor Gerontologie en Geriatrie 22, 15–19.Google ScholarPubMed
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R, Dunbar, GC (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl. 20), 22–33.Google ScholarPubMed
Shepard, RN, Metzler, J (1971). Mental rotation of three-dimensional objects. Science 171, 701–703.CrossRefGoogle ScholarPubMed
Sinor, AD, Irvin, SM, Greenberg, DA (2000). Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neuroscience Letters 278, 157–160.CrossRefGoogle ScholarPubMed
Sprague, JE, Everman, SL, Nichols, DE (1998). An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19, 427–441.Google Scholar
Topp, L, Barker, B, Degenhardt, L (2004). The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence 73, 33–40.CrossRefGoogle ScholarPubMed
Van der Elst, W, Van Boxtel, MP, Van Breukelen, GJ, Jolles, J (2005). Rey's verbal learning test: normative data for 1855 healthy participants aged 24–81 years and the influence of age, sex, education, and mode of presentation. Journal of the International Neuropsychological Society 11, 290–302.CrossRefGoogle ScholarPubMed
van Ours, JC (2005). Ecstasy and cocaine: patterns of use among prime age individuals in Amsterdam. Addictive Behaviors 30, 1468–1473.CrossRefGoogle ScholarPubMed
Wechsler, D (1981). WAIS-R Manual. The Psychological Corporation: San Antonio, TX.Google Scholar